Observational studyMedicine2025
Evolution of the global burden of vascular intestinal diseases in middle-aged and elderly population: Trend analysis from 1990 to 2021 and projections to 2040.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vascular intestinal diseases (VID), including mesenteric ischemia and ischemic colitis, are increasingly important public health issues, particularly among aging populations. However, their long-term epidemiological trends and future global burden remain underexplored. This observational cross-sectional study aimed to assess global VID trends from 1990 to 2021 and project future burden through 2040 using data from the Global Burden of Disease 2021 (GBD 2021) database. We extracted VID-related incidence, prevalence, and disability-adjusted life years (DALYs) data for individuals aged ≥45 years from GBD 2021. Age-standardized rates (ASRs) and estimated annual percentage change were used to quantify trends. Joinpoint regression, age-period-cohort analysis, decomposition analysis, and health inequality indices were applied to evaluate patterns and contributing factors. The Bayesian age-period-cohort model was used to project VID burden to 2040. From 1990 to 2021, global ASRs for VID showed a consistent decline: -0.49%/yr for incidence, -0.51% for prevalence, and -1.48% for DALYs. Despite this, the absolute number of VID cases and DALYs increased, driven primarily by population growth and aging. Age-period-cohort analysis revealed that VID risk rose with age but declined across successive birth cohorts. Decomposition analysis identified demographic changes as the main drivers of the increased burden. Health inequality metrics showed a narrowing of global disparities over time. Projections indicate continued increases in total VID cases by 2040, although ASRs are expected to decline further. The global burden of VID in middle-aged and elderly populations reflects both progress in disease control and emerging demographic challenges. While individual risk is decreasing, population aging continues to drive up the absolute burden. Efforts should prioritize early intervention, equitable healthcare access, and targeted public health strategies, particularly in low- and middle-sociodemographic index regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.